FLT3 and acute leukemia: To model the effects of NVP-BGT226 and NVP-BEZ235 on mutant-TK triggered AKT activation, we chose two well established acute leukemia cell lines harboring a FLT3 ITD mutation (MOLM14) or a BCR-ABL1 mutation (K562).